6368 related articles for article (PubMed ID: 3257967)
81. Monocytes enhance the bidirectional release of type I plasminogen activator inhibitor by endothelial cells.
Hakkert BC; Rentenaar JM; van Mourik JA
Blood; 1990 Dec; 76(11):2272-8. PubMed ID: 2257301
[TBL] [Abstract][Full Text] [Related]
82. Denaturant-induced stimulation of the beta-migrating plasminogen activator inhibitor in endothelial cells and serum.
Erickson LA; Hekman CM; Loskutoff DJ
Blood; 1986 Dec; 68(6):1298-305. PubMed ID: 2430646
[TBL] [Abstract][Full Text] [Related]
83. Phorbol ester increases plasminogen activator inhibitor accumulation in cultures of human granulosa cells.
Kessel B; Bicsak TA; Garzo VG
J Clin Endocrinol Metab; 1992 Jan; 74(1):33-8. PubMed ID: 1727827
[TBL] [Abstract][Full Text] [Related]
84. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.
Mimuro J; Schleef RR; Loskutoff DJ
Blood; 1987 Sep; 70(3):721-8. PubMed ID: 3113515
[TBL] [Abstract][Full Text] [Related]
85. Regulation of plasminogen activation in rat cell lines.
Reinders JH; Kaczmarek P; van Giezen JJ; Jansen JW
Ann N Y Acad Sci; 1992 Dec; 667():194-8. PubMed ID: 1285021
[TBL] [Abstract][Full Text] [Related]
86. Modulation of extracellular proteolytic activity and anchorage-independent growth of cultured cells by sarcoma cell-derived factors: relationships to transforming growth factor-beta.
Laiho M
Exp Cell Res; 1988 Jun; 176(2):297-308. PubMed ID: 3259933
[TBL] [Abstract][Full Text] [Related]
87. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Lindahl T; Wiman B
Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
[TBL] [Abstract][Full Text] [Related]
88. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.
Dosne AM; Dubor F; Lutcher F; Parant M; Chedid L
Thromb Res Suppl; 1988; 8():115-22. PubMed ID: 3144762
[TBL] [Abstract][Full Text] [Related]
89. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
Ginsburg D; Zeheb R; Yang AY; Rafferty UM; Andreasen PA; Nielsen L; Dano K; Lebo RV; Gelehrter TD
J Clin Invest; 1986 Dec; 78(6):1673-80. PubMed ID: 3097076
[TBL] [Abstract][Full Text] [Related]
90. Expression of plasminogen activator and plasminogen activator inhibitor by rat mesothelioma induced by asbestos.
Lenz SP; Green FH; Murphy PG; Lee M; Hart DA
Cancer Lett; 1993 Feb; 68(2-3):119-27. PubMed ID: 8443784
[TBL] [Abstract][Full Text] [Related]
91. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.
Hekman CM; Loskutoff DJ
Biochemistry; 1988 Apr; 27(8):2911-8. PubMed ID: 2969749
[TBL] [Abstract][Full Text] [Related]
92. Dexamethasone increases the release of three 44 kD proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary microvessel endothelial cells.
Partridge CA; Gerritsen ME
Thromb Res; 1990 Jan; 57(1):139-54. PubMed ID: 2300920
[TBL] [Abstract][Full Text] [Related]
93. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
Ye RD; Wun TC; Sadler JE
J Biol Chem; 1987 Mar; 262(8):3718-25. PubMed ID: 3029122
[TBL] [Abstract][Full Text] [Related]
94. Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2.
Hibino T; Izaki S; Ohkuma M; Kon S; Thorsen S; Astedt B
FEBS Lett; 1988 Apr; 231(1):202-6. PubMed ID: 3129308
[TBL] [Abstract][Full Text] [Related]
95. Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay.
Lund LR; Georg B; Nielsen LS; Mayer M; Danø K; Andreasen PA
Mol Cell Endocrinol; 1988 Nov; 60(1):43-53. PubMed ID: 3265112
[TBL] [Abstract][Full Text] [Related]
96. Inactivation of plasminogen activator inhibitor by oxidants.
Lawrence DA; Loskutoff DJ
Biochemistry; 1986 Oct; 25(21):6351-5. PubMed ID: 3098287
[TBL] [Abstract][Full Text] [Related]
97. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
Seiffert D; Wagner NN; Loskutoff DJ
J Cell Biol; 1990 Sep; 111(3):1283-91. PubMed ID: 1697297
[TBL] [Abstract][Full Text] [Related]
98. Binding of tissue plasminogen activator to human aortic endothelial cells.
Sanzo MA; Howard SC; Wittwer AJ; Cochrane HM
Biochem J; 1990 Jul; 269(2):475-82. PubMed ID: 2117440
[TBL] [Abstract][Full Text] [Related]
99. Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids.
Lambers JW; Cammenga M; König BW; Mertens K; Pannekoek H; van Mourik JA
J Biol Chem; 1987 Dec; 262(36):17492-6. PubMed ID: 3121598
[TBL] [Abstract][Full Text] [Related]
100. Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation.
O'Rourke J; Wang WP; Donnelly L; Wang E; Kreutzer DL
Am J Pathol; 1987 Feb; 126(2):334-42. PubMed ID: 3493701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
